Camlin Fine Sciences Limited has informed the Exchange regarding Notice of Postal Ballot
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 2.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Camlin Fine Sciences is seeking shareholder approval through a postal ballot (e-voting from September 30 to October 29, 2025) to issue up to 41,06,181 equity shares at ₹247.69 per share, totaling about ₹101.71 crore. These shares will be issued to five investors of Vinpai (a French functional ingredients company listed on Euronext Growth Paris) as non-cash consideration to acquire roughly 78.68% of Vinpai's share capital under a share purchase agreement signed on February 24, 2025. Along with the share swap, Camlin will also provide €3.3 million to Vinpai via convertible bonds. The allottees are Cyrille Damany, Philippe Le Ray, Alexandre Moranville, Chris Project, and Saffelberg Investments, with no promoter or director participation. Post-issue, promoter holding will dilute slightly from 49.08% to 48.03%, while public holding rises to 51.97%.
If approved, Camlin Fine Sciences will gain a majority stake in Vinpai, expanding its footprint into natural algae, plant, mineral, and fibre-based functional ingredients for food, cosmetics, and nutraceuticals markets across 36+ countries. Existing shareholders will see a small dilution (~2.2% on a fully diluted basis), but the swap is non-cash so no cash outflow is involved at the time of share issuance.